AKAM
53
2
DUK
57
2
CHD
48
-6
INTC
43
10
HRB
60
3
EA
59
-4
R
73
2
FSLR
49
-5
MOS
48
2
UAL
85
3
NWS
64
2
REGN
42
3
EFX
46
8
ZION
68
3
LMT
30
-4
SRE
54
-12
ALL
45
-6
FRT
50
4
OMC
64
2
DD
67
4
AKAM
53
2
DUK
57
2
CHD
48
-6
INTC
43
10
HRB
60
3
EA
59
-4
R
73
2
FSLR
49
-5
MOS
48
2
UAL
85
3
NWS
64
2
REGN
42
3
EFX
46
8
ZION
68
3
LMT
30
-4
SRE
54
-12
ALL
45
-6
FRT
50
4
OMC
64
2
DD
67
4
Financhill
Back

US Physical Therapy 10K Form

Buy
64

USPH
US Physical Therapy

Last Price:
98.63
Seasonality Move:
5.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive USPH News And Ratings

See the #1 stock for the next 7 days that we like better than USPH

USPH Financial Statistics

Sales & Book Value

Annual Sales: $604.8M
Cash Flow: $19.6M
Price / Cash Flow: 20.07
Annual Sales: $32.02
Price / Book: 3.06

Profitability

EPS (TTM): 1.70000
Net Income (TTM): $11.1M
Gross Margin: $121.51M
Return on Equity: 1.67%
Return on Assets: 1.09%

US Physical Therapy Earnings Forecast

Key US Physical Therapy Financial Ratios

  • The Gross Profit Margin over the past 33 years for USPH is 20.09%.
  • The Selling, General & Administrative Expenses for USPH have been equal to 0.00% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 63.40% of Operating Income.
  • The Net Earning history of USPH is 2.43% of Total Revenues.
  • Per Share Earnings over the last 33 years have been positive in 17 years.

US Physical Therapy Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: USPH
CUSIP: 90337L
Website: usph.com

Debt

Debt-to-Equity Ratio: 0.3
Current Ratio: 1.78
Quick Ratio: 1.68

Price-to-Earnings

Trailing P/E Ratio: 76.58
Forward P/E Ratio: 33.75

USPH Technical Analysis vs Fundamental Analysis

Buy
64
US Physical Therapy (USPH) is a Buy

Is US Physical Therapy a Buy or a Sell?